Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (3672)
All Articles published online
|
Publishing Process of This Article
|
May 6, 2024 (publication date) through Sep 26, 2025
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Wishahi M. Treatment-induced neuroendocrine prostate cancer and de novo neuroendocrine prostate cancer: Identification, prognosis and survival, genetic and epigenetic factors. World J Clin Cases 2024; 12(13): 2143-2146 [PMID: 38808339 DOI: 10.12998/wjcc.v12.i13.2143] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i13/2143.htm |
| Number | Citing Articles |
| 1 |
G. A. Kovchenko, A. V. Sivkov, L. N. Lyubchenko, A. D. Kaprin. Epigenetic abnormalities and neuroendocrine differentiation in prostate cancer. Siberian journal of oncology 2025; 24(1): 115 doi: 10.21294/1814-4861-2025-24-1-115-124
|
| 2 |
Rahul Aggarwal, Sylvie Rottey, Alice Bernard-Tessier, Begoña Mellado, Takeo Kosaka, Walter M. Stadler, Lisa Horvath, Richard Greil, Bert O’Neil, Bilal A. Siddiqui, Thomas Bauernhofer, Mehmet A. Bilen, Ferry Eskens, Shahneen Sandhu, Crystal Shaw, Chia Hsin Ju, Benjamin E. Decato, Brian Yu, Ana Aparicio. Safety and Efficacy of Tarlatamab in Patients with Neuroendocrine Prostate Cancer: Results from the Phase 1b DeLLpro-300 Study. Clinical Cancer Research 2025; 31(18): 3854 doi: 10.1158/1078-0432.CCR-25-1211
|
| 3 |
Wenwei Ying, Zhenshan Ding, Yuhui He, Jianfeng Wang, Xing Chen, Xuesong Li, Yanqing Gong. Surgery, radiotherapy and endocrine therapy for oligometastatic prostate cancer efficacy: a systematic review and network meta-analysis. PeerJ 2025; 13: e19819 doi: 10.7717/peerj.19819
|
| 4 |
Maoping Cai, Fengtao Zheng, Yang-Zi Ren, Chuqian Zhen, Dujiang Fu, Xian-Lu Song, Qing Li, Yuanyuan Qu, Zhe-Sheng Chen, Shan-Chao Zhao. New Insights into Potential Therapeutic Targets for Neuroendocrine Prostate Cancer: From Bench to Clinic. Research 2025; 8 doi: 10.34133/research.0791
|